Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Payment also leans on Bitcoin and Zelle rather than standard cards
Our physicians evaluate your specific needs to determine if this multi-peptide approach is more appropriate than single-peptide therapy for your situation
Throw away any unused medication after the expiration date
Retatrutide (LY3437943) is a first-in-class triple-receptor agonist peptide developed by Eli Lilly that simultaneously activates three metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon
The Metabolic Signaling Research Set is a dual-reagent kit featuring high-concentration NAD (1000mg) and 5-Amino-1MQ (10mg)
US$ 28.55
US$ 24.63
US$ 25.97
US$ 23.98
US$ 22.82
US$ 28.17
US$ 23.44
